Subscribe here to receive updates, including stories like these, via email. Or if you have your own blood cancer story to share, we’d love to hear from you.
Join Kate Arkadieff and Theresa Webb as they delve into non-Hodgkin's lymphoma & acute lymphoblastic leukaemia (leukemia) journeys for patients and families on the Talking Blood Cancer podcast by Leukaemia Foundation.
Discover how physiotherapist Julie Allen tackles cancer fatigue and lymphoma, enhancing the quality of life and survival for blood cancer patients.
In the ever-evolving landscape of blood cancer research, the quest to combat blood cancer continues to push boundaries. The New Directions in Leukaemia Research (NDLR) event in Adelaide last month brought together leading minds in the field to discuss breakthroughs, challenges, and the future of leukaemia treatment. From cutting-edge advancements in therapies to the promise of personalised medicine, the conference, sponsored by the Leukaemia Foundation, shed light on the latest discoveries and strategies shaping the fight against leukaemia.
Blood cancer casts a long shadow over many Australian families, but for Theresa Webb and her family, its shadow has been longer than most. Theresa was first diagnosed with blood cancer in 2002 after discovering a small hard lump near her collarbone. A biopsy revealed the then 30-year-old had a type of blood cancer called non-Hodgkin lymphoma.
To save more lives from AML, we urgently need to look past standard chemotherapy toward new, more effective approaches to treatment. Supported by Tour de Cure, one of our inaugural Breakthrough Fellowship recipients, Dr Ashwin Unnikrishnan, is doing just that.
Acute lymphoblastic leukaemia (ALL) is a type of blood cancer, which sees the body produce dangerous numbers of immature white blood cells. Supported by Tour de Cure, one of our inaugural Breakthrough Fellowship recipients, Dr Ashley Ng, is leading advanced research to improve our understanding of treatment-resistant ALL and develop new ways of beating it.
